Aurora Cannabis 

€6.4
1434
+€0.2+3.31% Aujourd'hui

Statistiques

Jour Haut
6.5
Journée basse
6.37
52W Haut
-
52W Bas
-
Volume
1,243
Volume moyen
-
Cap boursière
68.64M
Ratio C/B
3.57
Rendement de dividendes
-
Dividende
-

À venir

Bénéfices

7NovConfirmé
Q1 2024
Q2 2024
Suivant
-0.28
-0.16
-0.05
0.06
BPA prévu
-0.090394374285774
BPA réel
S. O.

Sont également suivis

Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent 21P.F. Il ne s'agit pas d'une recommandation d'investissement.

Concurrents

Cette liste est une analyse basée sur les événements récents du marché. Ce n'est pas une recommandation d'investissement.

À propos de nous

Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topicals kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. As of September 11, 2019, the company had operations in 25 countries across five continents. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Show more...
PDG
Mr. Michael Singer
Employés
2779
Pays
CA
ISIN
CA05156X8504
WKN
000A4ZZ0W

Cotation